Cargando…
Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma
The outcome of kidney renal clear cell carcinoma (KIRC) differs even among individuals with similar clinical characteristics. DNA methylation is regarded as a regulator of gene expression in cancers, which may be a molecular marker of prognosis. In this study, we aimed to mine novel methylation mark...
Autores principales: | Chen, Guang, Wang, Yihan, Wang, Lu, Xu, Wanhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354907/ https://www.ncbi.nlm.nih.gov/pubmed/28029655 http://dx.doi.org/10.18632/oncotarget.14134 |
Ejemplares similares
-
DNA methylation of Hugl‐2 is a prognostic biomarker in kidney renal clear cell carcinoma
por: Miao, Yi, et al.
Publicado: (2020) -
Aberrant Methylation of PCDH8 is a Potential Prognostic Biomarker for Patients with Clear Cell Renal Cell Carcinoma
por: Lin, Ying-Li, et al.
Publicado: (2014) -
LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma
por: Gong, Yun, et al.
Publicado: (2022) -
Four methylation‐driven genes may be prognostic biomarkers in clear cell renal carcinoma
por: Yin, Hang, et al.
Publicado: (2020) -
Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma
por: Liu, Xuehe, et al.
Publicado: (2023)